Skip to content

Other at other companies

Devon Energy logo
Devon EnergyDVN
0%
American International Group logo
American International GroupAIG
0.5%+0.2pp
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
-0.1%0.0pp
EyePoint, Inc.
 logo
EyePoint, Inc. EYPT
-0.3%-1.2pp
General Motors logo
General MotorsGM
-$4.5M
American International Group logo
American International GroupAIG
$5M+53.8%

Other financials

Income statement

See full
Revenue$317.0M-1.3%
Gross profit$183.4M+3.2%
Operating income$25.4M+59.3%
Net income$13.8M+129%
EPS (diluted)$0.45+137%

Balance sheet

See full
Cash & equivalents$35.0M-1.3%
Total debt$862.6M-3.6%
Total equity$1.0B+4.1%
Total assets$2.3B+0.8%

Cash flow

See full
Operating cash flow$13.5M-67.6%
CapEx$2.9M-23.5%
Free cash flow$10.6M-72.0%

Valuation

See full
Market cap$1.04B-35.6%
Enterprise value$1.87B-24.5%
P/E19×+5.4×
P/S0.8×-0.5×

Profitability

See full
Gross margin55.2%-1.0pp
Operating margin8.2%-5.6pp
Net margin4%-5.0pp
FCF margin9%-3.5pp

Returns & leverage

See full
Return on equity5.5%-7.5pp
Debt / equity0.8×-0.1×
Current ratio2.3×0.0×

Where this comes from

Reported directly by CONMED in its filing.

Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther.

The official record: CONMED’s 10-K, filed February 17, 2026, on SEC EDGAR. View the filing →

Ask your AI about CONMED's other.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CONMED's other?
CONMED (CNMD) reported other of $0.02 in Q4 2025.
How has CONMED's other changed year-over-year?
CONMED's other increased by 310.0% year-over-year, from $0.01 to $0.02.
What is the long-term trend for CONMED's other?
Over 4 years (2021 to 2025), CONMED's other has grown at a 78.9% compound annual growth rate (CAGR), from $0.01 to $0.08.